Detection of plasmid DNA vectors following gene transfer to the murine airways

被引:40
|
作者
Pringle, IA
Raman, S
Sharp, WW
Cheng, SH
Hyde, SC
Gill, DR
机构
[1] Univ Oxford, John Radcliffe Hosp, Genemed Res Grp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England
[2] United Kingdom Cyst Fibrosis Gene Therapy Consort, Oxford, England
[3] Univ Oxford, Inst Mol Med, ATR X Res Grp, Oxford, England
[4] Genzyme Corp, Cambridge, MA USA
基金
英国医学研究理事会;
关键词
gene transfer; plasmid DNA; lung gene expression; de novo methylation;
D O I
10.1038/sj.gt.3302518
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Non-viral gene therapy is being considered as a treatment for cystic fibrosis. In clinical studies and in studies using the mouse airways as a model, current formulations result in only transient transgene expression. A number of reasons for this have been proposed including the loss of plasmid DNA from cells. The aim of these studies was to investigate why transgene expression from non-viral vectors is transient in the mouse lung. Plasmid DNA encoding the luciferase reporter gene was complexed with the cationic lipid GL67 and delivered to the mouse airways. The persistence of plasmid DNA in the mouse lungs was investigated using quantitative PCR and Southern hybridization. Results showed that intact plasmid DNA persisted in the mouse lung in the absence of any detectable luciferase activity. The de novo methylation of plasmid DNA in vivo was investigated as a potential cause of this transient gene expression but results suggested that plasmid DNA does not become de novo methylated in the mouse lung. Therefore processes other than the loss of plasmid DNA from the lung or the de novo methylation of plasmid DNA vectors must be responsible for the transient transgene expression.
引用
收藏
页码:1206 / 1214
页数:9
相关论文
共 50 条
  • [41] Quantitative studies on the nuclear transport of plasmid DNA and gene expression employing nonviral vectors
    Tachibana, R
    Harashima, H
    Shinohara, Y
    Kiwada, H
    ADVANCED DRUG DELIVERY REVIEWS, 2001, 52 (03) : 219 - 226
  • [42] Study on a novel non-virus triplex gene vectors composed of plasmid DNA
    Song Cun-Xian
    Zhang Lin-Hua
    Zhang Chao
    Levy R J
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2007, 34 (08) : 830 - 835
  • [43] Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein-Barr virus (EBV)-based plasmid vectors
    Cui, FD
    Kishida, T
    Ohashi, S
    Asada, H
    Yasutomi, K
    Satoh, E
    Kubo, T
    Fushiki, S
    Imanishi, J
    Mazda, O
    GENE THERAPY, 2001, 8 (19) : 1508 - 1513
  • [44] Effects of Microfluidic Shear on the Plasmid DNA Structure: Implications for Polymeric Gene Delivery Vectors
    Andrew, Lucas J. J.
    Kly, Sundiata
    Moloney, Erin G. G.
    Moffitt, Matthew G. G.
    LANGMUIR, 2023, 39 (33) : 11545 - 11555
  • [45] PLASMID PERMUTATION VECTORS TO MONITOR DNA BENDING
    PRENTKI, P
    PHAM, MH
    GALAS, DJ
    NUCLEIC ACIDS RESEARCH, 1987, 15 (23) : 10060 - 10060
  • [46] Cationic lipid vectors for plasmid DNA delivery
    Hirko, A
    Tang, FX
    Hughes, JA
    CURRENT MEDICINAL CHEMISTRY, 2003, 10 (14) : 1185 - 1193
  • [47] Inhibition of murine VEGF gene expression using plasmid DNA expressing siRNA
    Lee, Y
    Kim, BS
    Rouse, BT
    FASEB JOURNAL, 2003, 17 (07): : C276 - C277
  • [48] High efficiency gene transfer to airways of mice using influenza hemagglutinin pseudotyped lentiviral vectors
    Patel, Manij
    Giddings, Angela M.
    Sechelski, John
    Olsen, John C.
    JOURNAL OF GENE MEDICINE, 2013, 15 (01): : 51 - 62
  • [49] The influence of DNA sequence on the immunostimulatory properties of plasmid DNA vectors
    Wloch, MK
    Pasquini, S
    Ertl, HCJ
    Pisetsky, DS
    HUMAN GENE THERAPY, 1998, 9 (10) : 1439 - 1447
  • [50] Immune responses following intramuscular plasmid gene transfer: A serious limitation for gene therapy?
    Maule, J
    McMahon, J
    Foster, K
    Kingston, R
    Wells, KE
    Wells, DJ
    IMMUNOLOGY, 1996, 89 : B16 - B16